Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorybpc-157tgansw healthgray market

NSW logs 1,180 emergency visits tied to unapproved peptide injections

Monthly presentations rose from five in July 2025 to more than 217 in September 2026, with liver injury cases admitted under a transplant service.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 18 14:00 ETSource: SMH.com.au

The wire

  1. 01An NSW Health report counts 1,180 emergency department presentations referencing unapproved peptide use between July 2025 and September 2026, including liver damage, allergic reactions and severe dehydration.
  2. 02Patients aged 25-34 made up 32% of presentations and 16-24 year-olds 25%; the RACGP has reported young people needing skin grafts and amputations after backyard injectables.
  3. 03Vial contents are unverified, says NSW Poisons Information Centre medical director Dr Darren Roberts, who called the practice "Russian roulette"; sellers market "research grade" products not approved by the TGA.

From the source

‘Russian roulette’: NSW emergency department visits surge amid dangerous peptide fad

Hundreds of patients a month are arriving at NSW emergency rooms after injecting unapproved peptides as a black market of injectables fuelled by wellness influencers booms in Australia.

Read at smh.com.au
PeptiPrescribed peptides from $99/moSee all →